The report on Peptide Therapeutics Market by drug class (luteinizing hormone (LH)-releasing hormone (LHRH),
somatostatins, glucagon and analogs, insulins, vasopressin), route of administration (oral, parental),
technology (liquid phase, solid phase, hybrid phase) trends analysis and forecasts up to 2023 studies the
market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-
Pacific, Rest of the World. According to the report the Global Peptide Therapeutics Market is projected to
grow at a CAGR between 9.0% to 9.5% in terms of value over the period of 2017-2023. The growth in the
world market is primarily driven by significant contribution by North America (Leading region) region to this
market.
Get a Sample Request:-
https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/956
Market Insights
Global peptide therapeutics market has experienced progressive growth over the past few years. Growth in
global market is highly credible to rising prevalence of metabolic disorder coupled with increasing pool of
cancer patient. Moreover, recent technological advancements have reduced production cost of peptide drugs
thereby fuelling growth remarkably in global market. Rising research activities and development pipeline of
peptide drugs anticipated to provide numerous growth opportunities over the forecast period. Although,
driven by aforementioned factors, growth in this market is hampered by complexity of peptide therapies may
limit manufacturing of peptide drugs.
Furthermore, consistently increasing cancer population across the globe with technological advancements
likely uncovers growth opportunities throughout the forecasted period. Additionally, increasing incidence of
metabolic disorders across the globe will also expected creating numerous growth opportunities in the
forthcoming years.
Infinium Global Research